CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 
 

KYMR's EPS Net Growth by Quarter and Year

Kymera Therapeutics Inc 's EPS Net results by quarter and year




KYMR EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.56 -0.39 0.00
III Quarter September -0.79 -0.55 0.00 0.00
II Quarter June -0.78 -0.29 0.00 0.00
I Quarter March -0.71 0.25 0.00 0.00
FY   -2.28 -1.15 -0.39 0.00



KYMR EPS Net third quarter 2022 Y/Y Growth Comment
Kymera Therapeutics Inc in the third quarter 2022 recorded EPS net loss of $ -0.79 .

According to the results reported in the third quarter 2022, Kymera Therapeutics Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While Kymera Therapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2022.




KYMR EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kymera Therapeutics Inc 's third quarter 2022 EPS Net $ -0.79 KYMR's Income Statement
Kymera Therapeutics Inc 's third quarter 2021 EPS Net $ -0.55 Quarterly KYMR's Income Statement
New: More KYMR's historic EPS Net Growth >>


KYMR EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kymera Therapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's III. Quarter Q/Q EPS Net Comment
Current results of -0.79 by Kymera Therapeutics Inc come out even worse considering the EPS net loss -0.78 in the second quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc achieved highest sequential EPS Net growth. While Kymera Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's III. Quarter Q/Q EPS Net Comment
Current accomplishment of -0.79 by Kymera Therapeutics Inc appear even less good compare to the -0.78 a quarter before.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc achieved highest sequential EPS Net growth. While Kymera Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Kymera Therapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative EPS Net 12 Months Ending $ -2.84 $ -2.60 $ -2.11 $ -1.15 $ -0.98
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Kymera Therapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -3 in the Sep 30 2022 period.
The situation is worsening as the cumulative EPS net loss is getting bigger from $ -2.6 for the period from Jun 30 2022 to Jun 30 2021 and $ -0.78 for the twelve months ending in the quarter Jun 30 2021.

Kymera Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Kymera Therapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -3 in the Sep 30 2022 period.
The results are getting worse as the cumulative EPS net loss is inflating from $ -2.6 in the twelve months ending a quarter before and $ -0.78 from the TTM period ending Jun 30 2021 Marc Martín mentioned.

Kymera Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
KYMR's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for KYMR's Competitors
EPS Net Growth for Kymera Therapeutics Inc 's Suppliers
EPS Net Growth for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Dividend Payout Ratio
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2022
Medpace Holdings Inc 58.91%$ 58.915 
Vir Biotechnology Inc 58.54%$ 58.537 
United Therapeutics Corporation43.57%$ 43.567 
Iradimed Corporation35.00%$ 35.000 
Zimmer Biomet Holdings Inc 33.33%$ 33.333 
Royalty Pharma Plc33.33%$ 33.333 
Eli Lilly And Company31.97%$ 31.967 
Bio techne Corp30.77%$ 30.769 
Merit Medical Systems Inc28.57%$ 28.571 
Corcept Therapeutics Inc25.00%$ 25.000 
Abbvie Inc 24.16%$ 24.157 
Repligen Corp22.41%$ 22.414 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MSGS's Profile

Stock Price

MSGS's Financials

Business Description

Fundamentals

Charts & Quotes

MSGS's News

Suppliers

MSGS's Competitors

Customers & Markets

Economic Indicators

MSGS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071